-
Mashup Score: 6ESGO Vulvar Cancer Guidelines 2023 with Maaike Oonk | IJGC Podcast - 2 month(s) ago
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Maaike Oonk to discuss the ESGO Vulvar Cancer Guidelines for 2023. Dr. Oonk is a gynaecological oncologist in the University Medical Center Groningen in the Netherlands. Her research focuses on new treatment options for vulvar cancer patients to improve quality of life. She is PI of the GROINSS-V studies and was chair of the 2023 ESGO vulvar cancer guidelines working group. Ā Highlights: Inguinofemoral radiotherapy is a safe alternative for a lymphadenectomy in patients with micrometastasis in the sentinel node. In case of unilateral sentinel node involvement, it is probably safe to omit treatment of the contralateral (sentinel node negative) groin. Studies are ongoing on application of the sentinel node procedure in locally recurrent disease, tumors > 4cm or multifocal tumors: outside these studies, the sentinel node procedure should only be applied in patients with unifocal primary squamous cell v
Source: ijgcbmj.podbean.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 10SHAPE Trial with Marie Plante | IJGC Podcast - 2 month(s) ago
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Marie Plante to discuss the SHAPE trial. Dr. Plante has a major interest in minimally invasive surgical (MIS) approaches in the treatment of gynecologic cancers and in fertility-preserving surgery for young women with cervical cancer. She is currently leading two important international trials the SHAPE trial and the Contessa trial. Highlights: In low-risk cervical cancer,Ā simple hysterectomy was not inferior to radical hysterectomy. There was no difference in overall adverse events between simple and radical hysterectomy. BetterĀ quality ofĀ life and sexual function was documented with simple hysterectomy compared to radical hysterectomy.
Source: ijgcbmj.podbean.comCategories: General Medicine News, Oncologists2Tweet-
RT @IJGConline: š„The #SHAPEtrial has been published! Listen again this episode with Dr. Plante šļø https://t.co/RnT0qSDsij @pedroramirezMDā¦
-
-
Mashup Score: 7Hormonal Therapy in Advanced or Recurrent Endometrial Cancer with Brian Slomovitz | IJGC Podcast - 6 month(s) ago
Ā In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Brian Slomovitz to discuss hormonal therapy in advanced or recurrent endometrial cancer. Dr. Slomovitz is a Gynecologic Oncologist at Mount Sinai Medical Center in Miami Beach, Florida, and Professor of Obstetrics and Gynecology at the Wertheim College of Medicine at Florida International University. He is an internationally recognized leader in gynecologic oncology clinical trials, specifically in immunotherapy and novel biomarker therapeutics. He also is a leader in sentinel lymph node detection for gynecologic malignancies. Highlights: While current recommendations include chemotherapy as first-line treatment for metastatic or recurrent endometrial cancer, emerging evidence suggests that hormonal therapy, particularly in combination with other treatment regimens guided by biomarkers, could be efficacious in selected subtypes (low-grade endometrioid carcinoma of the endometrium). Hormonal therapy
Source: ijgcbmj.podbean.comCategories: General Medicine News, Oncologists2Tweet-
RT @IJGConline: Listen to our new #WeeklyPodcast on #hormonal therapy in #endometrialcancers by @gyncancermd šļø https://t.co/x22OzG1yW4ā¦
-
-
Mashup Score: 5FIGO Endometrial Staging 2023 with Mario M. Leitao, Jr. and Andreas Obermair | IJGC Podcast - 8 month(s) ago
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs.Ā Mario Leitao and Andreas ObermairĀ to discussĀ FIGO endometrial staging. Dr. Mario Leitao is currently an Attending Surgeon in the Department of Surgery at Memorial Sloan Kettering Cancer Center and a Professor in the Department of Obstetrics and Gynecology at Weill Cornell Medical College. He currently serves as Program Director for the Gynecologic Oncology Fellowship. Dr. Leitao is also the Director for the Minimal Access and Robotic Surgery Program in the Department of Surgery for MSKCC. Dr. Andreas Obermair is an active gynaecological oncologist in public and private practice and a Professor of Gynaecological Oncology at The University of Queensland in Brisbane, Australia. He leads the Queensland Centre for Gynaecological Cancer Research to achieve less invasive and more effective treatments for gynaecological cancer. Ā Highlights: The new FIGO (staging) system is no longer a staging system to de
Source: ijgcbmj.podbean.comCategories: Latest Headlines, Oncologists1Tweet-
RT @IJGConline: š§ Listen to an expert take on #FIGO #endometrial #cancer #staging 2023 š https://t.co/WMD1Z2czra @leitaomd @AndreasObermaā¦
-
-
Mashup Score: 11FIGO Endometrial Staging 2023 with Mario M. Leitao, Jr. and Andreas Obermair | IJGC Podcast - 8 month(s) ago
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs.Ā Mario Leitao and Andreas ObermairĀ to discussĀ FIGO endometrial staging. Dr. Mario Leitao is currently an Attending Surgeon in the Department of Surgery at Memorial Sloan Kettering Cancer Center and a Professor in the Department of Obstetrics and Gynecology at Weill Cornell Medical College. He currently serves as Program Director for the Gynecologic Oncology Fellowship. Dr. Leitao is also the Director for the Minimal Access and Robotic Surgery Program in the Department of Surgery for MSKCC. Dr. Andreas Obermair is an active gynaecological oncologist in public and private practice and a Professor of Gynaecological Oncology at The University of Queensland in Brisbane, Australia. He leads the Queensland Centre for Gynaecological Cancer Research to achieve less invasive and more effective treatments for gynaecological cancer. Ā Highlights: The new FIGO (staging) system is no longer a staging system to de
Source: ijgcbmj.podbean.comCategories: Latest Headlines, Oncologists1Tweet-
Enjoy all!! Was so great to do this with my good friend @AndreasObermair @IJGConline @TeamEndo_MSK FIGO Endometrial Staging 2023 with Mario M. Leitao, Jr. and Andreas Obermair https://t.co/xD6rQRG5HZ
-
RT @IJGConline: #WeeklyPodcast #ESGO #Vulvar Cancer #Guidelines 2023 with Dr Maaike Oonk š§ https://t.co/oCYsdBuxWS @pedroramirezMD @HsuMā¦